Prognostic significance ofFLT3 internal tandem duplication andNPM1 mutations in acute myeloid leukemia in an unselected patient population
- Cite this article as:
- Suzuki, R., Onizuka, M., Kojima, M. et al. Int J Hematol (2007) 86: 422. doi:10.1007/BF02984000
- 63 Views
Mutations in the fms-like tyrosine kinase 3(FLT3) gene containing an internal tandem duplication(@#@ FLT3/ITD@#@) or mutations in the nucleophosmin 1 gene(NPM1) are thought to be prognostic indicators in acute myeloid leukemia (AML). Previous studies suggested that FLT3/ITD mutation indicates a poor prognosis and thatNPM1 mutation indicates a more favorable one, but these studies were often performed with selected patient populations. We investigated the clinical significance of these mutations at our institution with an unselected group of patients with newly diagnosed AML. This group included patients ≥60 years old and those with a poor performance status. Using polymerase chain reaction and sequencing analyses, we detected FLT3/ITD mutations in 12 patients (20.0%) andNPM1 mutations in 7 patients (11.7%) among a group of 60 patients. There was a nonsignificant trend for FLT3/ITD mutation to be associated with a poorer predicted overall survival (OS) probability in this population. In contrast, OS was significantly higher in patients with wild-typeNPM1 than in patients withNPM1 mutation, both for all AML patients and for AML patients with a normal karyotype. In this general and unselected AML patient population,NPM1 mutation was not a prognostic indicator of a favorable outcome.